Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 650
Selected: 0
NCT IDTitle
NCT03334305Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas
NCT00551460S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
NCT04871542Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
NCT05705401Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer
NCT03574753Lung-MAP S1400K: c-MET Positive
NCT01452672Resource-sparing Post-mastectomy Radiotherapy in Breast Cancer
NCT00075764S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
NCT02134912S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib
NCT03547999A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC
NCT00005036Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
NCT00053898Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
NCT00104949Trastuzumab in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma
NCT01674140S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
NCT02154490Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
NCT00003896S9912 Combination Chemo in Stage III Ovarian Cancer,
NCT00097110RCT of Antioxidant Therapy to Prevent Preeclampsia in Brazil
NCT04897568Shared Decision Making in Rural Primary Care Lung Cancer Screening and Smoking Cessation
NCT03557918Trial of Tremelimumab in Patients With Previously Treated Metastatic Urothelial Cancer
NCT00150917RCT of a Group Intervention for Women With a Family History of Breast Cancer
NCT00900484SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma
NCT06248606Adagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain Metastases
NCT00009906Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
NCT00055835S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium
NCT04624477Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer
NCT01515800S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer
NCT06031688Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
NCT00032123Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer
NCT00014222Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
NCT02728596S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
NCT00003140Letrozole After Tamoxifen in Treating Women With Breast Cancer
NCT06739655Preoperative Radiation Therapy and Immediate Breast Reconstruction
NCT00004125Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
NCT03654768Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia
NCT05254782Using ctDNA to Detect Minimal Residual Disease After Lung Cancer Resection
NCT04267913Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous Cell Lung Cancer (A Lung-MAP Treatment Trial)
NCT05929768Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
NCT00867048Strategic Timing of Antiretroviral Treatment
NCT01524991First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma
NCT04289779Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer
NCT05633615Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
NCT04711824Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases
NCT00002920S9630, Medroxyprogesterone in Treating Women With Breast Cancer
NCT00084435S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer
NCT00068289Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
NCT06686771Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
NCT00326898Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
NCT00438100Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer
NCT00005957Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer
NCT00002878Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma
NCT00003158S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer